Text of Comments by Mike Graglia to the CIRM Board re Funding of Rare Disease Research

Here is the text of remarks by Mike Graglia, managing director of the SynGap Research Fund, that he delivered to the CIRM governing board on June 27, 2024. See this article — $3.9 Billion Left for California's Stem Cell and Gene Therapy Program; What Will it Finance? — for more about the priority review at CIRM.

-0-

Thank you for the opportunity to speak.

…